A Perspective on India’s Fight against COVID - 19

Anil Kumar
{"title":"A Perspective on India’s Fight against COVID - 19","authors":"Anil Kumar","doi":"10.24321/2455.7048.202005","DOIUrl":null,"url":null,"abstract":"The COVID - 19 pandemic which has affected 209 countries/ territories, infected more than a million persons and claimed more than 50 thousands human lives worldwide (till 4th April, 2020). It is caused by SARS-CoV-2 a novel virus genetically similar to SARS virus and reported first in Wuhan, China. In India, the first case was reported in January and until 5th April, 2020 it has spread to 29 States/UTs, affected more than 3 thousand. The fate of this disease in India is to be determined by three elements of epidemiology, i.e. agent, host and environment. The agent is novel, but it has been reported that there are two strains of SARS-CoV-2 under circulation out of which one is more aggressive and spread quickly. As the susceptibility to the virus is there in Indian population, like other countries but its presentation in hosts which range from asymptomatic to severe pneumonia would be affected by the innate immunity of hosts and small proportion of population belonging to high risk group. In addition, the weather of India may also act as an impediment to the fatalities this disease may cause. The measures taken by India first to restrict the entry of this agent in community and further to interrupt its transmission are exemplary. However, still there is need to be future ready and plan strategically, learning from success and failure of other countries. In order to tackle this pandemic, there is need to strengthen the existing medical infrastructure to take care of advance stage of COVID-19 patients and quality epidemiological investigation of COVID - 19 cases at the community level. \nHow to cite this article:Karotia D, Kumar A. A Perspective on India’s Fight against COVID - 19. Epidem Int 2020; 5(1): 22-28.","PeriodicalId":89674,"journal":{"name":"Epidemiology Research International","volume":"60 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Epidemiology Research International","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24321/2455.7048.202005","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 8

Abstract

The COVID - 19 pandemic which has affected 209 countries/ territories, infected more than a million persons and claimed more than 50 thousands human lives worldwide (till 4th April, 2020). It is caused by SARS-CoV-2 a novel virus genetically similar to SARS virus and reported first in Wuhan, China. In India, the first case was reported in January and until 5th April, 2020 it has spread to 29 States/UTs, affected more than 3 thousand. The fate of this disease in India is to be determined by three elements of epidemiology, i.e. agent, host and environment. The agent is novel, but it has been reported that there are two strains of SARS-CoV-2 under circulation out of which one is more aggressive and spread quickly. As the susceptibility to the virus is there in Indian population, like other countries but its presentation in hosts which range from asymptomatic to severe pneumonia would be affected by the innate immunity of hosts and small proportion of population belonging to high risk group. In addition, the weather of India may also act as an impediment to the fatalities this disease may cause. The measures taken by India first to restrict the entry of this agent in community and further to interrupt its transmission are exemplary. However, still there is need to be future ready and plan strategically, learning from success and failure of other countries. In order to tackle this pandemic, there is need to strengthen the existing medical infrastructure to take care of advance stage of COVID-19 patients and quality epidemiological investigation of COVID - 19 cases at the community level. How to cite this article:Karotia D, Kumar A. A Perspective on India’s Fight against COVID - 19. Epidem Int 2020; 5(1): 22-28.
印度抗击COVID - 19的视角
截至2020年4月4日,COVID - 19大流行已影响到209个国家/地区,感染了100多万人,夺去了全球5万多人的生命。它是由SARS- cov -2引起的,这是一种与SARS病毒基因相似的新型病毒,在中国武汉首次报道。在印度,1月份报告了第一例病例,到2020年4月5日,它已蔓延到29个邦/区,影响了3000多人。该病在印度的命运将取决于流行病学的三个因素,即病原体、宿主和环境。这种病原体是新型的,但据报道,有两种SARS-CoV-2菌株正在流通,其中一种更具攻击性,传播速度更快。与其他国家一样,印度人口对该病毒具有易感性,但其在宿主(从无症状到严重肺炎)中的表现将受到宿主先天免疫和属于高风险群体的一小部分人口的影响。此外,印度的天气也可能阻碍这种疾病可能造成的死亡。印度首先为限制这一病原体进入社区并进一步中断其传播所采取的措施具有示范意义。然而,仍然需要为未来做好准备和战略规划,从其他国家的成功和失败中学习。为了应对这一流行病,需要加强现有的医疗基础设施,以照顾COVID-19晚期患者,并在社区一级对COVID-19病例进行高质量的流行病学调查。本文作者:Karotia D, Kumar A.从印度抗击新冠肺炎的角度看问题。2020年流行病学;5(1): 22。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信